The pharmaceutical giant known as AbbVie has announced that it will close 75 jobs in its Galway-based plant.
According to RTE News, it is understood operations there will cease by the end of the year.
The plant was first opened by Zeltiq in 2016, but then it changed hands just one year later to Allergan, a company that AbbVie acquired.
The Galway site served as a manufacturing hub for a product designed to combat and reduce body fat.
Despite the unfortunate news, AbbVie says it will engage with workers and that redeployment opportunities will be offered to those who wish to avail of them.
The company has other facilities in Sligo, Cork and Dublin, along with former Allergan owned operations in Westport and Dublin.
The news follows just one month after AbbVie won an appeal against the Irish Tax Appeals Commission (ITAC) after it was hit with a stamp-duty bill worth a whopping €572 million.
The company received the bill after it acquired the Botox maker Allergan for $63bn (around €57.2 billion).
The huge tax bill resulted from a move by Minister for Finance Paschal Donohoe in October 2019.
For more business news from Newsday.ie, click here.